New York State Common Retirement Fund Castle Biosciences Inc Transaction History
New York State Common Retirement Fund
- $75.2 Billion
- Q2 2025
A detailed history of New York State Common Retirement Fund transactions in Castle Biosciences Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 215,830 shares of CSTL stock, worth $4.97 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
215,830
Previous 163,159
32.28%
Holding current value
$4.97 Million
Previous $3.27 Million
34.94%
% of portfolio
0.01%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding CSTL
# of Institutions
171Shares Held
27.3MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.04MShares$70.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$49.9 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.8MShares$41.4 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.49MShares$34.3 Million2.2% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.38MShares$31.7 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $605M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...